Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1573 of 5804
-
Electric heart boost: new device shows promise for failing hearts
Disease control CompletedPatients with idiopathic dilative cardiomyopathy who have systolic left ventricular dysfunction (NYHA III - IV) despite adequate therapy according to treatment guidelines of heart failure and who have a baseline left ventricular ejection fraction of ≥25% and ≤35 will receive a C-…
Phase: NA • Sponsor: Berlin Heals GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New study tests if ocrevus improves walking in MS patients
Disease control OngoingThe purpose of this study is to test if people with relapsing multiple sclerosis (RMS) can improve ambulatory functions after one-year treatment with Ocrevus in comparison with other Disease Modifying Treatments (DMT). Sixty qualified individuals with RMS will be evenly assigned …
Phase: PHASE4 • Sponsor: Georgia State University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for rare Skin-Hardening disease
Disease control CompletedTo evaluate the efficacy of MT-7117 treatment in subjects with diffuse cutaneous systemic sclerosis (dcSSc) using the American College of Rheumatology Composite Response Index in Diffuse Systemic Sclerosis (ACR CRISS) at Week 52
Phase: PHASE2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a Two-Drug combo beat aspirin alone for preventing clots after joint surgery?
Disease control CompletedConsented patients undergoing elective total hip and total knee arthroplasty will be randomized to receive either aspirin alone or aspirin and rivaroxaban for prevention of venous thromboembolism.
Phase: PHASE3 • Sponsor: Sudeep Shivakumar • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo shows promise in early AML trial
Disease control OngoingThis phase Ib trial studies the side effects and best dose of navtemadlin when given together with the standard chemotherapy drugs cytarabine and idarubicin in patients with acute myeloid leukemia. Navtemadlin may stop the growth of cancer cells by blocking a protein called MDM2 …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Quick urine test could help people with HIV stay on track
Disease control OngoingThis study seeks to determine the clinical efficacy and cost effectiveness of implementing an integrated model for HIV monitoring using point of care (POC) tenofovir (TFV) adherence testing and POC viral load (VL) monitoring in improving ART adherence, maintaining durable VL supp…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug pegcetacoplan tested in teens with rare blood disorder
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, effectiveness, and biological activity (how the investigational medication is processed by the body) of pegcetacoplan in 12-17 year-olds (adolescents) who have paroxysmal nocturnal hemoglobinuria (PNH).
Phase: PHASE2 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Diabetes drug shows promise for dangerous low sodium condition
Disease control Recruiting nowHyponatremia is the most common electrolyte derangement occurring in hospitalized patients. It is usually classified as hypovolemic, euvolemic or hypervolemic. The most common aetiology of euvolemic hyponatremia is the syndrome of inappropriate antidiuresis (SIAD). Hypervolemic h…
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New radiation strategy before brain surgery shows promise
Disease control CompletedSTEP is a French multicentre, prospective, non-randomized, phase II study designed to assess 6-months local control after pre-operative stereotactic radiosurgery (SRS) for patients with brain metastases
Phase: PHASE2 • Sponsor: Centre Jean Perrin • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Statins show promise for slowing macular degeneration in new trial
Disease control Recruiting nowinterventional trial for off label use of high dose atorvastatin 80 mg in intermediate AMD patients and correlate recovery response measured by dark adaptation recovery time with drusen volume reduction measured by SD-OCT
Phase: PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Liquid biopsy could predict who benefits from Post-Chemo breast cancer pill
Knowledge-focused Recruiting nowThe purpose of the study is to evaluate the use of a circulating tumor DNA (ctDNA) assay, ie, a "liquid biopsy," as a tool to identify triple-negative breast cancer (TNBC) patients who will or will not experience benefit from treatment with capecitabine. Participants will be moni…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New pill could stop painful swelling attacks in rare disease
Symptom relief CompletedThis study evaluates the efficacy of orally administered deucrictibant for the acute treatment of attacks in patients with hereditary angioedema (HAE). Eligible subjects are randomized to one of three single doses of deucrictibant and placebo. The study will compare symptom relie…
Phase: PHASE2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New drug cocktail shows early promise for tough lung cancer
Disease control OngoingThis study will assess safety, tolerability, and treatment activity of datopotamab deruxtecan (Dato-DXd) in combination with immunotherapy with or without carboplatin in participants with advanced or metastatic non-small cell lung cancer (NSCLC).
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New proton beam therapy aims to cut side effects in prostate cancer treatment
Disease control Recruiting nowThis phase II trial investigates whether proton radiation therapy directed to the prostate tumor, pelvic, and para-aortic lymph nodes, is an effective way to treat patients with high-risk or lymph node positive prostate cancer who are receiving radiation therapy, and if it will r…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Ear stimulation device offers hope for kids with lingering concussion or COVID symptoms
Symptom relief Recruiting nowThe purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (a Neurostim device) on children with pain and Post Concussion symptoms. An additional purpose of this study is to demonstrate that PENFS improves functioning in children…
Phase: NA • Sponsor: Children's Hospital of Orange County • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
MRI-Guided radiation zaps prostate tumors with fewer side effects?
Disease control Recruiting now1. To investigate the tolerability of MR-linac based stereotactic ablative radiotherapy (MRL-SBRT)for patients with localized prostate cancer 2. To assess the acute and late toxicities, efficacy and quality of life for patients treated by MRL-SBRT 3. To simulate the dose planning…
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could adding a second drug boost bone strength in osteoporosis?
Disease control OngoingThis randomized open label clinical trial will evaluate the effect of continued denosumab alone over 18 months versus denosumab with added abaloparatide for 18 months. 70 postmenopausal women will be enrolled over a period of 18 months. The co-primary outcomes will be group diffe…
Phase: PHASE4 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New MRI technique aims to sharpen bladder cancer staging
Diagnosis CompletedThe therapeutic approach to bladder cancer is strongly dependent on tumor stage and grade. Patients with non-muscle-invasive tumors (NMIBC) are usually treated with surgical resection of the tumor alone, whereas patients with muscle-invasive tumors (MIBC) ideally undergo neoadjuv…
Phase: NA • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Shocking the brain back to life: VR and zaps may restore arm movement after stroke
Symptom relief CompletedThe study aims to determine the added value of combining high-definition transcranial direct current stimulation (HD-tDCS) in a rehabilitation program based on virtual reality therapy (VRT) to potentiate the effects on neuroplasticity and further improve functional recovery of th…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Could an asthma drug shield knees from arthritis after ACL surgery?
Disease control Recruiting nowThis is a multicenter randomized, placebo-controlled trial to assess whether a 6-month course of oral montelukast after ACL reconstruction reduces systemic markers of inflammation and biochemical and imaging biomarkers of cartilage degradation. This study will specifically target…
Phase: EARLY_PHASE1 • Sponsor: Austin V Stone • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC